Your browser doesn't support javascript.
loading
Medical Journal of Mashad University of Medical Sciences. 2007; 50 (96): 230-234
en Persa | IMEMR | ID: emr-128368
ABSTRACT
Warfarin is an anticoagulant drug, reducing the synthesis of vitamin K dependent coagulant factors. It has fewer complications than heparin during pregnancy, but it passes easily through the placenta. Therefore it may induce unfavorable condition so called as fetal warfarinsyndrome. The common presentations of this syndrome are nasal hypoplasia, epiphysial calcification, and skeletal disorders. Fetuses exposed to warfarin in the first trimester of pregnancy have an increased risk of embryopathy [nasal hypoplasia and stippled epiphyses]. A male neonate with new symptoms of fetal embryopathy [femoral agenesis bilateral dislocation of hip, agenesis of corpus callozom] is presented. He was born postdate from a mother using warfarin 2.5 mg/kg during the whole pregnancy. He also had short lower limb, finger deformity, nasal hypoplasia, radioulnar dislocation, hydrocephaly, and brachiocephaly
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Persa Revista: Med. J. Mashad Univ. Med. Sci. Año: 2007

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Persa Revista: Med. J. Mashad Univ. Med. Sci. Año: 2007